Targeted DNA RNA Sequencing Market Research: Evaluating Cost-Effectiveness and Value

 The global targeted DNA RNA sequencing market size is expected to reach USD 34.56 billion in 2030 and is projected to grow at a CAGR of 19.4% from 2024 to 2030. Targeted Sequencing has emerged as a key technology in life science research by enabling examination of a specific region of interest while keeping the seq. cost as well as the complexity of data under manageable limits.

 

This approach enhances sequencing depth by allowing the evaluation of specific coding regions within genes or specific genes, which are known to harbor mutations for disease pathogenesis. Several research projects have employed this technology to avoid wastage of information and extra cost and study only relevant genes. The number of such projects continues to grow, consequently driving the market.

 

Innovations to address the pitfalls of targeted enrichment methods are anticipated to enhance the usage rate of this technology throughout the forecast period. Moreover, with a decrease in seq-cost and improvement in informatics, targeted methods have become more accessible for use in clinical settings than ever.

 

 

Access the Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report By Product (NGS), By Workflow (Pre-sequencing), By Application, By Technology, By Type, By End Use, And Segment Forecasts, 2024 - 2030

 

 

Targeted DNA RNA Sequencing Market Report Highlights

·        Rapid advancements in NGS and its ancillary protocols can be attributed to the growth of this segment.

 

·        Out of all the NGS-based targeted methods, exome-seq held the largest share.

 

·        This can be attributed to the fact that though it accounts for less than 2% of the genome, it contains 85% of the known disease-relevant variants.

 

·        Entire targeted approach is broken down into presequencing, sequence determination, and data analysis.

 

·        Being the most crucial step, sequencing accounted for the largest share.

 

·        This space has revolutionized various applications of life sciences, including human biomedical research, plant & animal sciences, drug discovery, and others.

 

·        Out of all, human biomedical research is estimated to be the largest application of this space due to its high usage in studying disease pathogenesis.

 

·        The targeted DNA/RNA sequencing market is bifurcated into DNA-seq and RNA-seq, based on the sample type.

 

·        DNA-sequencing has been estimated to generate higher revenue over its counterpart segment. This can be attributed to the presence of a wide range of products and kits for DNA-seq.

 

·        As per end use, academic research is estimated to be the largest segment owing to the increase in seq-based projects at universities and other academic centers.

 

·        North America held the largest share owing to the presence of effective regulations pertaining to approval of genetic tests and bioinformatics tools.

 

·        Moreover, the U.S. is observed to have the highest number of installed sequencers, which in turn, has contributed to the large share of the North America regional market.

 

·        Asia Pacific is expected to emerge as the fastest growing regional market.

 

·        Rise in genome-based projects coupled with constant GDP growth in Asian countries is expected to drive the Asia Pacific market.

 

 

Key Targeted DNA RNA Sequencing Company Insights

Some key companies in the global targeted DNA RNA sequencing market include Illumina, F. Hoffman La-Roche Ltd, QIAGEN, Bio-Rad Laboratories, and others. Vendors in the market are focusing on increasing their customer base to gain a competitive edge in the industry. Therefore, key players undertake several strategic initiatives, such as mergers, acquisitions, and partnerships with other major companies.

 

Illumina is among the world’s foremost makers of genomic equipment including DNA sequencing and microarray technology. Their products assist researchers and healthcare providers with information that can be used to diagnose diseases, develop individualized treatments, and progress various scientific disciplines related to genetics.

 

Roche is a leading healthcare company, dedicated to research and innovation in pharmaceutical and diagnostic products. They own leading clinical products in oncology, immunology, and diagnostic products for personalized medicine.

 

 

Order your free sample copy of “Targeted DNA RNA Sequencing Market Report 2024 - 2030, published by Grand View Research

 

 

Key Targeted DNA RNA Sequencing Companies:

The following are the leading companies in the targeted DNA RNA sequencing market. These companies collectively hold the largest market share and dictate industry trends.

 

·        Illumina

·        F. Hoffman-La Roche Ltd.

·        QIAGEN

·        Thermo Fisher Scientific, Inc.

·        Bio-Rad Laboratories, Inc.

·        Oxford Nanopore Technologies

·        PierianDx

·        Genomatix GmbH

·        DNASTAR, Inc.

·        Perkin Elmer, Inc.

 

Recent Developments

·        In June 2024, Bio-Rad launched a new ddSEQ Single-Cell 3' RNA-Seq Kit to support single-cell gene expression research. This kit enables researchers to affordably and rapidly analyze gene expression on the single-cell resolution. It is anticipated that this technology will help in the research of oncology, immunology, and more.

 

·        In May 2024, a new paper was published in Genomic Medicine highlighting global efforts to increase access to genome sequencing for diagnosing rare genetic disorders and focusing on its potential to improve diagnosis speed and reduce healthcare costs. The Medical Genome Initiative calls for broader insurance coverage, reduced administrative barriers, and increased clinician education to support the widespread adoption of genome sequencing.

 

About Grand View Research:

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

 

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone:-1-415-349-0058

Email: sales@grandviewresearch.com

 

 

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more